Summary
An acute reduction in the synaptic availability of serotonin (5HT) by p-chlorophenlalanine (PCPA) nullifies the decrease in the density of cortical beta adrenoceptors caused by desipramine (DMI) but does not appreciably alter the attenuation of the norepinephrine (NE) sensitive adenylate cyclase. The analysis of competition-binding curves of [3H]-dihydroalprenolol shows that the affinity of the agonist (−)-isoproterenol for cortical beta adrenoceptors is profoundly reduced following PCPA. This reduction in agonist affinity is enhanced by DMI. Resupplying 5HT by by-passing trptophan hydroxylase inhibition, by administering 5-hydroxytryptophan, converts a DMI non-responsive to a DMI responsive beta adrenoceptor population and shifts the markedly decreased agonist affinity towards the affinity values found in control preparations. The results demonstrate the pivotal role of 5HT in the regulation of the density and agonist affinity characteristics of cortical beta adrenoceptors and contribute to the scientific basis of the ‘serotonin-norepinephrine link hypothesis’ of affective disorders.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Blumberg, J.B., Vetulani, J., Stawarz R.F., and Sulser, F., The noradrenergic cyclic AMP generating system in the limbic forebrain: Pharmacological characterization and possible role in the mode of action of antipsychotics. Eur. J. Pharmac.37 (1976) 357–366.
Brunello, N., Barbaccia, M.L., Chuang, D.M., and Costa, E., Downregulation of β-adrenergic receptors following repeated injections of desmethylimipramine: Permissive role of serotonergic axons. Neuropharmacology21 (1982) 1145–1149.
Bylund, D. B., and Snyder, S. H., Beta adrenergic receptor binding in membrane preparations from mammalian brain. Molec. Pharmac.12 (1976) 568–580.
Dumbrille-Ross, A., and Tang, S. W., Noradrenergic and serotonergic input necessary for imipramine-induced changes in beta but not S2 receptor densities. Psychiatry Res.9 (1983) 207–215.
Gilbert, R. F. T., Bennett, G. W., Marsden, C. A., and Emson, P. C., The effects of 5-hydroxytryptamine depleting drugs on peptides in the ventral spinal cord. Eur. J. Pharmac.76 (1981) 203–210.
Gilman, A. G., A protein binding assay for adenosine 3′, 5′ cyclic monophosphate. Proc. natl. Acad. Sci. USA67 (1970) 305–312.
Janowsky, A., Steranka, L. R., Gillespie, D. D., and Sulser, F., Role of neuronal signal input in the down-regulation of central noradrenergic receptor function by antidepressant drugs. J. Neurochem.39 (1982) 290–292.
Janowsky, A., Okada, F., Manier, D. H., Applegate, C. D., Steranka, L. R., and Sulser, P., Role of serotonergic input in the regulation of the \-adrenergic receptor coupled adenylate cyclase system. Science218 (1982) 900–901.
Lowry, D. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., Protein measurement with the folin phenol reagent. J. biol. Chem.193 (1951) 265–275.
Manier, D. H., Okada, F., Janowsky, A. J., Steranka, L. R., and Sulser, F., Serotonergic denervation changes binding characteristics of beta adrenoceptors in rat cortex. Eur. J. Pharmac.86 (1983) 137–139.
Mishra, R., Gillespie, D. D., Lovell, R., Robson, R. D., and Sulser, F., Oxaprotiline: Induction of central noradrenergic subsensitivity by its (+)-enantiomer. Life Sci.30 (1982) 1747–1755.
Mishra, R., Gillespie, D. D., Youdim, M., and Sulser, F., Selective MAO inhibition and noradrenergic receptor function in rat cortex. Psychopharmacology81 (1983) 220–223.
Mishra, R., Leith, N. J., Steranka, L., and Sulser, F., The noradrenaline receptor coupled adenylate cyclase system in brain. Naunyn-Schmiedeberg's Arch. Pharmac.316 (1981) 218–224.
Pastan, I. H., and Willingham, M. C., Journey to the center of the cell: Role of the receptosome. Science214 (1981) 504–509.
Scatchard, G., The attractions of proteins for small molecules and ions. Ann. N.Y. Acad. Sci.51 (1949) 660–672.
Schweitzer, J. W., Schwartz, R., and Friedhoff, A. J., Intact presynaptic terminals required for beta-adrenergic receptor regulation by desipramine. J. Neurochem.33 (1979) 377–379.
Scott, J. A., and Crews, F. T., Rapid decrease in rat brain beta adrenergic receptor binding during combined antidepressant alpha2 antagonist treatment. J. Pharmac. exp. Ther.224 (1983) 640–646.
Shopsin, B., Friedman, E., and Gershon, S., The use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients. Psychopharmac. Commun.1 (1975) 239–249.
Shopsin, B., Friedman, E., and Gershon, S., Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients. Archs. gen. Psychiat.33 (1976) 811–819.
Stadel, M. M., Strulovici, B., Nambi, P., Lavin, T. N., Briggs, M. M., Caron, M. G., and Lefkowitz, J., Desensitization of the β-adrenergic receptor of frog erythrocytes. J. biol. Chem.258 (1983) 3032–3038.
Sulser, F., Noradrenergic receptor regulation and the action of antidepressants, in: Depression and Antidepressants — Recent Events, pp. 24–36. Excerpta Medica, Amsterdam 1983.
Sulser, F., The ‘Serotonin-Noradrenaline Link Hypothesis’ of affective disorders, in: Proc. IIIrd World Congress of Psychiatry. Plenum Press, New York 1984 (in press).
Wolfe, B. B., Harden, T. K., Sportn, J. R., and Molinoff, P. B., Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants. J. Pharmac. exp. Ther.207 (1978) 446–457.
Author information
Authors and Affiliations
Additional information
Acknowledgments. This work was supported by USPHS grant MH-29228 and the Tennessee Department of Mental Health and Mental Retardation. Present address of L. R. Sterank: NOVA Pharmaceutical Corporation, Baltimore (MD 21228, USA).
Rights and permissions
About this article
Cite this article
Manier, D.H., Gillespie, D.D., Steranka, L.R. et al. A pivotal role for serotonin (5HT) in the regulation of beta adrenoceptors by antidepressants: reversibility of the action of parachlorophenylalanine by 5-hydroxytroptophan. Experientia 40, 1223–1226 (1984). https://doi.org/10.1007/BF01946651
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01946651